Cyril Fersing is an associate professor of Medicinal Chemistry at the Faculty of Pharmacy of Montpellier and at the Institut des Biomolécules Max Mousseron (IBMM) since 2018. He also maintains hospital activity as a radiopharmacist at the Montpellier Cancer Institute (ICM), primarily focusing on clinical research. At the end of his Pharmacy Practice Residency (2013-2018), he received his PharmD degree from Aix-Marseille University. In parallel with his hospital course, he graduated with a PhD in Medicinal Chemistry from Aix-Marseille University in 2018. To match with his current hospital pharmacy activities, bringing together his growing expertise in oncology pharmacy and his experience in heterocyclic medicinal chemistry, Cyril Fersing has directed his research toward the field of cancerology. His research at the ICM consists in the study and optimization of the radiolabeling conditions of theranostic probes; his major research interest at the IBMM focuses on small heterocyclic molecules for targeted enzyme inhibition or degradation.